RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 167 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $66,000 | +112.9% | 56,347 | +106.9% | 0.00% | – |
Q2 2022 | $31,000 | -70.5% | 27,239 | -22.2% | 0.00% | -100.0% |
Q1 2022 | $105,000 | +20.7% | 35,029 | +6.3% | 0.00% | – |
Q4 2021 | $87,000 | -12.1% | 32,961 | +20.9% | 0.00% | -100.0% |
Q3 2021 | $99,000 | +2.1% | 27,260 | +21.9% | 0.00% | 0.0% |
Q2 2021 | $97,000 | +49.2% | 22,354 | +17.4% | 0.00% | – |
Q1 2021 | $65,000 | +20.4% | 19,044 | +23.1% | 0.00% | – |
Q4 2020 | $54,000 | -8.5% | 15,476 | -15.1% | 0.00% | – |
Q3 2018 | $59,000 | -33.0% | 18,239 | -41.6% | 0.00% | -100.0% |
Q2 2018 | $88,000 | -19.3% | 31,254 | +1.3% | 0.00% | 0.0% |
Q1 2018 | $109,000 | -39.8% | 30,868 | -33.9% | 0.00% | 0.0% |
Q4 2017 | $181,000 | +2916.7% | 46,680 | +1531.0% | 0.00% | – |
Q3 2014 | $6,000 | -40.0% | 2,862 | 0.0% | 0.00% | – |
Q2 2014 | $10,000 | -23.1% | 2,862 | -13.7% | 0.00% | – |
Q1 2014 | $13,000 | +44.4% | 3,315 | +1.6% | 0.00% | – |
Q4 2013 | $9,000 | -77.5% | 3,263 | -70.5% | 0.00% | – |
Q3 2013 | $40,000 | +100.0% | 11,043 | +86.1% | 0.00% | – |
Q2 2013 | $20,000 | – | 5,934 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |